Authors:
MAY TW
RAMBECK B
JURGES U
BLANKENHORN V
JURGENS U
Citation: Tw. May et al., COMPARISON OF TOTAL AND FREE PHENYTOIN SERUM CONCENTRATIONS MEASURED BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND STANDARD TDX ASSAY - IMPLICATIONS FOR THE PREDICTION OF FREE PHENYTOIN SERUM CONCENTRATIONS, Therapeutic drug monitoring, 20(6), 1998, pp. 619-623
Authors:
RAMBECK B
KURLEMANN G
STODIECK SRG
MAY TW
JURGENS U
Citation: B. Rambeck et al., CONCENTRATIONS OF LAMOTRIGINE IN A MOTHER ON LAMOTRIGINE TREATMENT AND HER NEWBORN CHILD, European Journal of Clinical Pharmacology, 51(6), 1997, pp. 481-484
Authors:
SCHNABEL R
RAMBECK B
MAY T
JURGENS U
LAHL R
FRITSCH W
Citation: R. Schnabel et al., LACK OF INFLUENCE OF HISTOPATHOLOGICAL CHANGES ON CARBAMAZEPINE AND CARBAMAZEPINE-10,11-EPOXIDE CONCENTRATIONS IN THE BRAIN CORTEX OF EPILEPTIC PATIENTS (VOL 141, PG 87, 1996), Journal of the neurological sciences, 147(2), 1997, pp. 223-224
Citation: Uh. Juergens et al., SIMULTANEOUS HPLC DETERMINATION OF VIGABATRIN AND GABAPENTIN IN SERUMWITH AUTOMATED PRE-INJECTION DERIVATIZATION, Journal of liquid chromatography & related technologies, 19(9), 1996, pp. 1459-1471
Authors:
SCHNABEL R
RAMBECK B
MAY T
JURGENS U
LAHL R
Citation: R. Schnabel et al., RELATIONSHIP BETWEEN ISCHEMIC DAMAGE AND CONCENTRATIONS OF PHENYTOIN AND PHENOBARBITAL IN THE BRAIN CORTEX OF EPILEPTIC PATIENTS IN VEGETATIVE STATE AT DEATH, Epilepsy research, 25(3), 1996, pp. 231-241
Citation: Tw. May et al., SERUM CONCENTRATIONS OF LAMOTRIGINE IN EPILEPTIC PATIENTS - THE INFLUENCE OF DOSE AND COMEDICATION, Therapeutic drug monitoring, 18(5), 1996, pp. 523-531
Authors:
SCHNABEL R
RAMBECK B
MAY TW
JURGENS U
LAHL R
VILLAGRAN R
Citation: R. Schnabel et al., LACK OF EFFECT OF HISTOLOGICAL LESIONS ON THE PHENYTOIN AND PHENOBARBITAL CONCENTRATIONS IN THE BRAIN CORTEX OF EPILEPTIC PATIENTS (VOL 133, PG 177, 1995), Journal of the neurological sciences, 144(1-2), 1996, pp. 231-232
Authors:
SCHNABEL R
RAMBECK B
MAY T
JURGENS U
LAHL R
FRITSCH W
Citation: R. Schnabel et al., LACK OF INFLUENCE OF HISTOPATHOLOGICAL CHANGES ON CARBAMAZEPINE AND CARBAMAZEPINE-10,11-EPOXIDE CONCENTRATIONS IN THE BRAIN CORTEX OF EPILEPTIC PATIENTS, Journal of the neurological sciences, 141(1-2), 1996, pp. 87-94
Citation: Tw. May et al., FLUCTUATIONS OF 10-HYDROXY-CARBAZEPINE DURING THE DAY IN EPILEPTIC PATIENTS, Acta neurologica Scandinavica, 93(6), 1996, pp. 393-397
Authors:
SCHNABEL R
RAMBECK B
MAY TW
JURGENS U
LAHL R
VILLAGRAN R
Citation: R. Schnabel et al., LACK OF EFFECT OF HISTOLOGICAL LESIONS ON THE PHENYTOIN AND PHENOBARBITAL CONCENTRATIONS IN THE BRAIN CORTEX OF EPILEPTIC PATIENTS, Journal of the neurological sciences, 133(1-2), 1995, pp. 177-182
Citation: V. Blankenhorn et al., DRUG-MONITORING OF ANTIEPILEPTIC DRUGS - COMPARISON OF 2 ANALYTICAL METHODS - HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND ENZYME-IMMUNOASSAY, Epilepsia, 36, 1995, pp. 157-157
Authors:
RAMBECK B
MAY TW
JURGENS U
BLANKENHORN V
JURGES U
KORNMERKER E
Citation: B. Rambeck et al., COMPARISON OF PHENYTOIN AND CARBAMAZEPINE SERUM CONCENTRATIONS MEASURED BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, THE STANDARD TDX ASSAY, THE ENZYME-MULTIPLIED IMMUNOASSAY TECHNIQUE, AND A NEW PATIENT-SIDE IMMUNOASSAY CARTRIDGE SYSTEM, Therapeutic drug monitoring, 16(6), 1994, pp. 608-612
Authors:
SCHNABEL R
RAMBECK B
MAY TW
JURGENS U
LAHL R
Citation: R. Schnabel et al., CONCENTRATIONS OF CARBAMAZEPINE AND CARBAMAZEPINE-10,11-EPOXIDE IN SERUM, BRAIN-TUMORS AND PARATUMOROUS CORTEX - A PROSPECTIVE-STUDY OF 37 NEUROSURGICALLY TREATED EPILEPTIC PATIENTS, European neurology, 34(4), 1994, pp. 213-220
Authors:
SCHNABEL R
RAMBECK B
MAY T
JURGENS U
LAHL R
Citation: R. Schnabel et al., EFFICACY OF CARBAMAZEPINE WITH RESPECT TO DISTRIBUTION OF CARBAMAZEPINE AND ITS METABOLITE 10,11-EPOXIDE IN CEREBRAL-TUMORS AND PARATUMOROUS CORTEX, Acta neurologica Scandinavica, 90(2), 1994, pp. 133-134